Clinical Trial Detail

NCT ID NCT03337698
Title A Study Evaluating ThA Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Non-Small Cell Lung Cancer (Morpheus Lung)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab + Carboplatin + Gemcitabine

Atezolizumab + CPI-444

Atezolizumab

Atezolizumab + Docetaxel

Docetaxel

Atezolizumab + Cobimetinib

Atezolizumab + Carboplatin + Pemetrexed

Atezolizumab + RO6958688

Age Groups: adult senior

No variant requirements are available.